Drug Research
Development of biologics: The market requires short development times and high productivity
Biologics offer new therapy options for numerous diseases: They are already used to treat cancer and autoimmune diseases such as rheumatoid arthritis as useful alternatives to standard therapies. The extent of their market potential is revealed...
Drug Research
OPTIMA pharma started a cooperation with Charité and the Berlin Institute of Health
Optima Pharma and Charité – Universitätsmedizin Berlin are developing a concept for the automated production and filling of cell and gene therapeutics. These new types of medications are considered a promising new therapy opportunity for incurable...
Articles
Addressing the challenges of BYOD: is the industry over cautious?
Over recent years, the rise of Electronic Clinical Outcome Assessments (eCOA) solutions has opened up a host of opportunities to researchers.
By allowing participants to easily submit information during a clinical trial via devices such as tablets, computers, handheld devices and...
Drug Research
Digital Science welcomes Gigantum and Ripeta to the family to help increase reproducibility in research
Digital Science, a technology company serving stakeholders across the research ecosystem, welcomes two US-based startups to the Digital Science family of companies: automated reproducibility assessment tool, Ripeta, and data science platform, Gigantum. Both companies are playing...
Drug Research
HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases
Science ignored the presence of the heavy hydrogen, deuterium (D) in living organisms for 60 years since its discovery by Harold C. Urey in the early 30’s, despite the fact, that the concentration of deuterium is 6-time higher than...
Drug Research
Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
Biocartis Group NV , an innovative molecular diagnostics company announced the signing of a collaboration agreement with Bristol-Myers Squibb Company , a global biopharmaceutical company, aimed at the potential registration as a companion diagnostic and use of the IdyllaTM...
Articles
Implementing a more structured approach to analytical method development
The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed extensively over recent years.
The modern concept of method lifecycle management (MLCM) provides a framework for defining the criteria and development of analytical methods, aiming...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
